Project Grant R21AI186312
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$223K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Alabama, USA
Similar Awards
This $567,962 project grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases will fund research at the University of Alabama at Birmingham from March 2022 to February 2027 under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will support research into the coordination of innate and adaptive immunity in intestinal barrier defense. Specifically, the grantee will define the mechanisms by which innate and adaptive immune...
This Project Grant award in the amount of $884,454 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research aimed at investigating the immunomodulatory effects of secondary bile acids produced by the gut bacterium [Ruminococcus] gnavus. The research team is engineering a two-strain bacterial consortium to toggle the production of the secondary bile acid isodeoxycholic...
This federal Project Grant award, in the amount of $148,568.00, is funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to elucidate the role of the bacteria Akkermansia muciniphila in promoting vaginal colonization and ascending infection by Group B Streptococcus (GBS) in pregnant women. The research will utilize a mouse model and human cell studies to investigate mechanisms by...
This federal Project Grant award of $389,500.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will fund research at the University of Chicago to study the role of alpha-defensins, a type of antimicrobial peptide, in regulating the gut microbiome and host responses to intestinal pathogens. The proposed research aims to use CRISPR/Cas9 gene editing and gnotobiotic (germ-free)...
This federal Project Grant award, totaling $438,608, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of this grant is to investigate the role of host genetics in shaping the intestinal Lactobacillus population using a murine model. Specifically, the research aims to determine the mechanisms by which host genetics directly influence the population of Lactobacillus murinus, a...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to understand the mechanisms by which the gut bacterium Phocaeicola vulgatus (PVu) colonizes the mammalian gut and competes with other microbes. The $122,786 award to Duke University will fund in vitro studies to characterize the functions of a specific PVu operon involved in fitness and gut colonization, as...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $315,270 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The General Hospital Corporation (doing business as Massachusetts General Hospital) to establish a new therapeutic strategy for inflammatory bowel disease (IBD) that leverages the role of cholinergic innervation in mediating intestinal inflammation. The key objectives of this research project are to: 1) determine the mechanism by which...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $318,085 to support research aimed at understanding the role of cells, antigens, and antibodies in controlling virus infections through Fc-dependent mechanisms. The key objectives of the research are to: Assess the molecular determinants that govern how natural killer (NK) cells use antibody-dependent cellular...
This federal Project Grant award of $578,093 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research into the immunobiology of a novel human DAMP receptor and its murine homolog, including their ligand. The award was made to the University of Massachusetts Medical School (UMass Medical), a prominent research institution and medical school experienced in securing federal grants and contracts....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $125,160 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Ohio State University to characterize a novel bacterial immune system. The research aims to use cryo-electron microscopy and biochemical assays to define the structure and assembly mechanisms of a bacterial immune complex consisting of two components, A and B, which are predicted to have ATPase and nuclease functions,...